MF:EURONEXT PARISWendel SE Analysis

Manulife Financial is trading comfortably above its 20‑day, 50‑day and 200‑day simple moving averages, confirming a bullish price trend despite a recent bearish MACD crossover. Volume is on the rise, supporting the upward momentum, while the RSI sits near the midpoint, indicating neither overbought nor oversold conditions. The stock currently respects a clear support zone just above 36.9 and faces resistance near 40.4, with the market price positioned in the middle of that range. An attractive dividend yield of roughly 3½ % and a payout ratio just above 50 % suggest a sustainable income stream backed by strong operating cash flow. Valuation metrics point to a discount relative to peers, with a P/E below the industry average and a DCF‑derived fair value markedly higher than the current price, implying upside potential.
Fundamentally, the company delivered 12 % revenue growth and maintains healthy gross and operating margins, while its balance sheet shows ample cash and a moderate debt‑to‑equity profile. Free cash flow generation comfortably exceeds dividend obligations, reinforcing the view that the payout is sustainable. The blend of steady earnings, solid capital returns and a resilient business model across North America and Asia offsets the elevated 30‑day volatility and near‑market‑neutral beta. Overall, the combination of technical strength, undervalued fundamentals and a reliable dividend makes Manulife a compelling candidate for investors across horizons.